Device Trial Radar · NCT00882661
SECURE®-C Cervical Artificial Disc Clinical Study/ SECURE-C Cervical Artificial Disc Postmarket Approval Study
Last checked: Nov 20, 2026Latest source record: Jun 9, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
380
Actual
Start
Jul 2005
Primary completion
Apr 2010
Study completion Feb 2017
Sponsor
- Lead sponsor
- Globus Medical IncPublic (GMED)
- Sponsor type
- Industry
- First posted
- Apr 16, 2009
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the pivotal IDE clinical study was to evaluate the safety and effectiveness of the SECURE®-C Cervical Artificial Disc for the treatment of symptomatic cervical disc disease at one level between C3 and C7, compared to anterior cervical discectomy and fusion. The purpose of the Postmarket Approval Study is to evaluate the long-term safety and efficacy associated with the use of the SECURE-C Cervical Artificial Disc
Conditions
- Symptomatic Cervical Disc Disease
Interventions
SECURE-C Cervical Artificial DiscDevice
Treatment of symptomatic cervical disc disease with the SECURE-C Cervical Artificial Disc
ASSURE Cervical plate and an allograft interbody spacerDevice
Treatment of symptomatic cervical disc disease utilizing an instrumented anterior discectomy and interbody fusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Individual Patient Overall SuccessTime frame: 24 months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.